The public issue is entirely an offer-for-sale (OFS) of up to 21.7 million shares by the promoters and other shareholders to the tune of around ₹1,800 crore, said bankers. The company operates under the “Blue Jet” brand offering niche products targeted at innovator pharmaceutical companies and multinational generic pharmaceutical companies.
Violent crypto attacks rise as criminals hunt bigger payouts
Physical attacks targeting cryptocurrency holders surged 33% globally in the first half of 2026, with losses soaring to $124 million. France emerged as the epicentre
July 25, 2026